Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Authors
Tina Cascone,
William WilliamAnnikka Weissferdt,
Cheuk Leung,
Heather Lin,
Apar Pataer,
Myrna Godoy,
Brett Carter,
Lorenzo Federico,
Alexandre Reuben,
M.A. Khan,
Hitoshi Dejima,
Alejandro Francisco‐Cruz,
Edwin Parra,
Luisa Solis,
Junya Fujimoto,
Hai Tran,
Neda Kalhor,
Frank Fossella,
Frank Mott,
Anne Tsao,
George Blumenschein,
Xiuning Le,
Jianjun Zhang,
Ferdinandos Skoulidis,
Jonathan Kurie,
Mehmet Altan,
Charles Lu,
Bonnie Glisson,
Lauren Byers,
Yasir Elamin,
Reza Mehran,
David Rice,
Garrett Walsh,
Wayne Hofstetter,
Jack Roth,
Mara Antonoff,
Humam Kadara,
Cara Haymaker,
Chantale Bernatchez,
Nadim Ajami,
Robert Jenq,
Padmanee Sharma,
James Allison,
P. Futreal,
Jennifer Wargo,
Ignacio Wistuba,
Stephen Swisher,
J. Lee,
Don Gibbons,
Ara Vaporciyan,
John Heymach,
Boris Sepesi,
Álejandro Cruz +52 authors
,
John Lee Tip Tip